NeuroCME
EXPERT VIDEOCME

Clinical Advances in the Management of Tardive Dyskinesia

Author(s)/Faculty: Hubert H. Fernandez, MD; Karen E. Anderson, MD; Joohi Jimenez-Shahed, MD
Release Date: 7/19/2017Expiration Date: 7/18/2018
Credit Type: CMENumber of Credits: 0.75
Content Type: VideoProvider:
Tardive dyskinesia (TD) is a neurological disorder characterized by involuntary movements that can affect any part of the body. This disabling movement disorder affects more than 570,000 people in the United States and approximately 20% to 30% of patients who are taking long-term antipsychotic agents. Until recently, there was a lack of tolerable and effective treatment options for TD. However, encouraging advances in treatment point to promising new therapies that address the unmet medical needs of patients with TD. In this roundtable discussion, recorded shortly after the 2017 International Congress of Parkinson's Disease and Movement Disorders in Vancouver, BC, Canada, leading experts discuss the burden of TD and early recognition and intervention, as well as the latest data on treatment. This activity will enable health care providers caring for patients with TD to become more aware of new evidence and to appropriately utilize the information to improve patient care.